Checkpoint Inhibition in Myeloma: Opportunities and Challenges

Checkpoint Inhibition in Myeloma: Opportunities and Challenges

Despite major improvements in the treatment landscape, most multiple myeloma (MM) patients eventually succumb to the underlying malignancy. Immunotherapy represents an attractive strategy to achieve durable remissions due to its specificity and capacity for long term memory. Activation of immune cel...

Full description

Bibliographic Details
Main Authors: Federica Costa, Rituparna Das, Jithendra Kini Bailur, Kavita Dhodapkar, Madhav V. Dhodapkar
Format: Article
Language:English
Published: Frontiers Media S.A. 2018-09-01
Series:Frontiers in Immunology
Subjects:
myeloma
immunotherapy
immune checkpoint
PD-1
PD-L1
Online Access:https://www.frontiersin.org/article/10.3389/fimmu.2018.02204/full

Internet

https://www.frontiersin.org/article/10.3389/fimmu.2018.02204/full

Similar Items